All In MedTech

Device Trial Radar · NCT04441333

Usability, Safety and Efficacy of AspivixTM

Usability, Safety and Efficacy of AspivixTM, an Atraumatic Innovative Uterine Cervical Traction Device: a Pilot Phase Followed by a Comparative Study (Pilot)

Last checked: Nov 20, 2026Latest source record: Dec 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

13

Actual

Start

Jul 1, 2020

Primary completion

Dec 2, 2020

Study completion Dec 2, 2020

Sponsor

Lead sponsor
Aspivix SANot on our public-company list
Sponsor type
Industry
First posted
Jun 22, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Limited mobility of the uterine cervix and alignment with the vaginal canal is often required during insertion of an intrauterine contraceptive device (IUD). Currently, the available instruments are traumatic tenacula, which could cause pain and bleeding and therefore represent an obstacle for certain patients to pursue their medical follow-up. AspivixTM is a new device, which enables atraumatic traction of the cervix while respecting its specific semi-circular anatomic shape through a system powered by a vacuum chamber. The aim of our pilot study is to assess the usability, safety and efficacy of the device. Note: Study is made of 2 phases (pilot phase followed by a comparative phase). Details regarding comparative study is registered separately.

Conditions

  • IUD Insertion

Interventions

  • AspivixTM cervical vacuum tenaculumDevice

    Traction of the cervix for IUD insertion using the AspivixTM cervical vacuum tenaculum

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Usability and efficacy from the practitioner's perspective: questionnaireTime frame: Right after the use of the device (right after the end of the procedure to insert the IUD).

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department Women, Mother & Child, University Hospital

    Lausanne, Canton of Vaud, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.